Bromodomain containing protein 4 inhibitor - Kainos Medicines
Alternative Names: BRD4 inhibitor-Kainos MedicineLatest Information Update: 12 Jul 2022
At a glance
- Originator Kainos Medicines
- Developer Kainos Medicines; Unnamed company
- Class Antineoplastics
- Mechanism of Action BRD4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 07 Jul 2022 Early research in Cancer in South Korea (unspecified route) (Kainos medicine Pipeline, July 2022)